Literature DB >> 10947338

Valuing health-related quality of life. A review of health state valuation techniques.

C Green1, J Brazier, M Deverill.   

Abstract

Given the growing need to value health-related quality of life, a review of the literature relating to health state valuation techniques was undertaken to appraise the current theoretical and empirical evidence available to inform on the techniques, to identify consensus, identify disagreement and identify important areas for future research. A systematic search of the literature was conducted, covering standard gamble (SG), time trade-off (TTO), visual analogue scale (VAS), magnitude estimation (ME) and person trade-off (PTO) techniques. The basic concepts of practicality, reliability, theoretical validity and empirical validity formed the criteria for reviewing the performance of valuation techniques. In terms of practicality and reliability, we found little evidence relating to ME and PTO. SG, TTO and VAS have been shown to be practical on a range of populations. There is little difference between the reliability of SG, TTO and VAS, and present evidence does not offer a basis to differentiate between them. When considering the theoretical basis of techniques, we conclude that choice-based methods (i.e. SG, TTO and PTO) are best placed to reflect the strength of preference for health, with the choice between these techniques depending on the study characteristics and the perspective employed. Empirical evidence relating to the theoretical perspective of the techniques has shown that there are problems with all techniques in terms of descriptive validity.

Entities:  

Mesh:

Year:  2000        PMID: 10947338     DOI: 10.2165/00019053-200017020-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  76 in total

Review 1.  The use of QALYs in health care decision making.

Authors:  G Loomes; L McKenzie
Journal:  Soc Sci Med       Date:  1989       Impact factor: 4.634

2.  Valuation of health states by the general public: feasibility of a standardized measurement procedure.

Authors:  M L Essink-Bot; G J Bonsel; P J van der Maas
Journal:  Soc Sci Med       Date:  1990       Impact factor: 4.634

3.  Measurement of the validity of utility elicitations performed by computerized interview.

Authors:  L A Lenert; S Morss; M K Goldstein; M R Bergen; W O Faustman; A M Garber
Journal:  Med Care       Date:  1997-09       Impact factor: 2.983

4.  An experimental test of a theoretical foundation for rating-scale valuations.

Authors:  H Bleichrodt; M Johannesson
Journal:  Med Decis Making       Date:  1997 Apr-Jun       Impact factor: 2.583

5.  A utility assessment of oral and intravenous ganciclovir for the maintenance treatment of AIDS-related cytomegalovirus retinitis.

Authors:  E S Johnson; S D Sullivan; E Mozaffari; P C Langley; N J Bodsworth
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

Review 6.  Utility approach to measuring health-related quality of life.

Authors:  G W Torrance
Journal:  J Chronic Dis       Date:  1987

7.  Methods for measuring levels of well-being for a health status index.

Authors:  D L Patrick; J W Bush; M M Chen
Journal:  Health Serv Res       Date:  1973       Impact factor: 3.402

8.  Preferences for outcomes in economic evaluation: an economic approach to addressing economic problems.

Authors:  A Gafni; S Birch
Journal:  Soc Sci Med       Date:  1995-03       Impact factor: 4.634

9.  The measurement of patients' values in medicine.

Authors:  H Llewellyn-Thomas; H J Sutherland; R Tibshirani; A Ciampi; J E Till; N F Boyd
Journal:  Med Decis Making       Date:  1982       Impact factor: 2.583

10.  Methodological issues of patient utility measurement. Experience from two clinical trials.

Authors:  M P Rutten-van Mölken; C H Bakker; E K van Doorslaer; S van der Linden
Journal:  Med Care       Date:  1995-09       Impact factor: 2.983

View more
  69 in total

1.  Valuation of depression co-occurring with a somatic condition: feasibility of the time trade-off task.

Authors:  Katerina Papageorgiou; Karin M Vermeulen; Fenna R M Leijten; Erik Buskens; Adelita V Ranchor; Maya J Schroevers
Journal:  Health Expect       Date:  2014-11-13       Impact factor: 3.377

Review 2.  The development and use of quality-of-life measures to evaluate health outcomes in Japan.

Authors:  Shunichi Fukuhara; Naoki Ikegami; George W Torrance; Shuzo Nishimura; Michael Drummond; François Schubert
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients.

Authors:  Francis S Lobo; Cynthia R Gross; Barbara J Matthees
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

4.  Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile function.

Authors:  G W Torrance; M A Keresteci; R W Casey; A J Rosner; N Ryan; M C Breton
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

5.  The stability of utility scores: test-retest reliability and the interpretation of utility scores in elective total hip arthroplasty.

Authors:  D Feeny; C M Blanchard; J L Mahon; R Bourne; C Rorabeck; L Stitt; S Webster-Bogaert
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

6.  Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.

Authors:  Mangala Rajan; Kuan-Chi Lai; Chin-Lin Tseng; Shirley Qian; Alfredo Selim; Lewis Kazis; Leonard Pogach; Anushua Sinha
Journal:  Qual Life Res       Date:  2012-03-06       Impact factor: 4.147

7.  The disutility of restenosis--the impact of repeat percutaneous coronary intervention on quality of life.

Authors:  Marleen M J Ploegmakers; Anneke M Viscaal; Lois Finch; Nancy E Mayo; James M Brophy
Journal:  Can J Cardiol       Date:  2010 Jun-Jul       Impact factor: 5.223

8.  Validity of standard gamble utilities in patients referred for aortic valve replacement.

Authors:  Amjad I Hussain; Andrew M Garratt; Jan Otto Beitnes; Lars Gullestad; Kjell I Pettersen
Journal:  Qual Life Res       Date:  2015-11-24       Impact factor: 4.147

9.  Mapping the cancer-specific FACT-B onto the generic SF-6Dv2.

Authors:  Azin Nahvijou; Hossein Safari; Mahmood Yousefi; Marziyeh Rajabi; Morteza Arab-Zozani; Hosein Ameri
Journal:  Breast Cancer       Date:  2020-07-25       Impact factor: 4.239

10.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.